The most intensive medical obesity therapy in the pipeline is retatrutide. Retatrutide is the "triple G," a glucose dependent insulinotropic polypeptide (GIP), glucagon like peptide 1 (GLP 1), and glucagon receptor agonist. It has demonstrated robust blood Retatrutide Retatrutide Research Peptide Triple Agonist PurePeptix Australia Cagrilintide: The Next Gen Peptide for Weight Loss and Satiety Hubmed retatrutide and cagrilintide 15mg 5mg EZP 3P EZP CG Blend 12.5mg 2.5mg Research Grade Compound